Tubigon, Jessy Elaine -.
HRN: 20-93-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2023
CEFUROXIME 750MG (VIAL)
08/20/2023
08/27/2023
IV
280mg
Q8
AGE
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes